Ming Yang
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research 54
- MicroRNA in disease regulation 25
- Molecular Biology top 1%
- RNA modifications and cancer 50
- RNA Research and Splicing 25
- Epigenetics and DNA Methylation 20
- Cancer-related gene regulation 18
- Circular RNAs in diseases 18
- Oncology top 2%
-
- Lung Cancer Treatments and Mutations 17
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ming Yang
188 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Cancer Research 2.9k
- Molecular Biology 4.3k
- Oncology 1.2k
- Pathology and Forensic Medicine 433
- Pulmonary and Respiratory Medicine 771
Countries citing papers authored by Ming Yang
This map shows the geographic impact of Ming Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Yang more than expected).
Fields of papers citing papers by Ming Yang
This network shows the impact of papers produced by Ming Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Yang. The network helps show where Ming Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ming Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 12 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 6 | |
| 8 | [Salidroside alleviates retinopathy in diabetes rats by inhibiting oxidative stress and immune inflammation through activating PI3K/AKT pathway]. | 2023 | 0 |
| 9 | 2023 | 1 | |
| 10 | 2022 | 64 | |
| 11 | 2020 | 5 | |
| 12 | 2020 | 6 | |
| 13 | 2019 | 1 | |
| 14 | 2018 | 8 | |
| 15 | 2018 | 31 | |
| 16 | 2013 | 157 | |
| 17 | 2009 | 36 | |
| 18 | 2008 | 104 | |
| 19 | 2008 | 44 | |
| 20 | 2008 | 138 |
About Ming Yang
Ming Yang is a scholar working on Cancer Research, Molecular Biology, Oncology, Applied Microbiology and Biotechnology and Pulmonary and Respiratory Medicine, having authored 194 papers that have together received 6.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (54 papers), RNA modifications and cancer (50 papers), MicroRNA in disease regulation (25 papers), RNA Research and Splicing (25 papers), Epigenetics and DNA Methylation (20 papers), Cancer-related gene regulation (18 papers), Circular RNAs in diseases (18 papers) and Lung Cancer Treatments and Mutations (17 papers). The work is most often cited by research in Cancer Research (2.9k citations), Molecular Biology (4.3k citations), Oncology (1.2k citations), Pathology and Forensic Medicine (433 citations) and Pulmonary and Respiratory Medicine (771 citations). Ming Yang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Nasha Zhang, Liqing Zhou, Dongxin Lin, Qipeng Yuan, Changchun Zhou, Wen Tan, Dianke Yu, Wenting Pan, Ling Wei and Liyan Lv. Their work appears in journals such as Scientific Reports, Cancer Letters, Carcinogenesis, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.